Atlas Trials

Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab

Clinical trial NCT02386566 · COMPLETED

Trial details

NCT number
NCT02386566
Sponsor
Biogen
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2015-03-20
Primary completion
2018-01-28
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.